More tools:Markets·Screener·Research·Chat

Picard Medical, Inc. (PMI) Financial Statements

Picard Medical, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001T9HQK8
XASE · usd
4.41▲ 0.10 (2.32%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.31
Day's Range4.05 – 4.65
52-Week Range0.09 – 13.68
Volume239.4K
Avg Volume4.0M
Share Statistics
Shares Outstanding
Employees75
ExchangeXASE
Listed2025-08-29
Share count as of August 18, 2026
Loading Income Statement…
Key questions about Picard Medical, Inc. (PMI)
What is Picard Medical, Inc.'s Market Cap?
Picard Medical, Inc.'s Market Cap is $10.3M, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s Enterprise Value?
Picard Medical, Inc.'s Enterprise Value is $10.4M, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s Price / Sales?
Picard Medical, Inc.'s Price / Sales is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s EV / Revenue?
Picard Medical, Inc.'s EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s EV / EBITDA?
Picard Medical, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s Revenue (TTM)?
Picard Medical, Inc.'s Revenue (TTM) is $6.3M, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s Net Income (TTM)?
Picard Medical, Inc.'s Net Income (TTM) is -$28.0M, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s EBITDA?
Picard Medical, Inc.'s EBITDA is -$15.5M, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s Diluted EPS (TTM)?
Picard Medical, Inc.'s Diluted EPS (TTM) is -11.97, based on as-reported figures from SEC (XBRL) filings.
What is Picard Medical, Inc.'s EBITDA Margin?
Picard Medical, Inc.'s EBITDA Margin is -245.4%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Revenues, net:
Revenues
YoY growth+38.6%+85.5%+20.7%+34.7%
Cost of revenues:
Cost of revenues
Gross profit (loss)
% of revenue20.9%23.9%40.7%-11.0%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue177.6%416.2%338.4%282.8%
Operating loss
% of revenue-156.7%-392.3%-297.6%-293.8%
Other income (expenses):
Interest expense
Derivative loss
Change in fair value of senior secured note and warrant liability——
Gain (Loss) on Extinguishment of Debt——
Loss on warrant exchange———
Other income———
Total other income (expenses), net
Loss before income taxes
Provision for income taxes
Net loss
% of revenue-191.6%-662.3%-425.3%-878.3%
Undeclared Series A-1 preferred dividends
Net loss attributable to common stockholders
Net loss per share—basic and diluted (in dollars per share)—